Quality & complianceOfficial

FDA classifies Fresenius DELFLEX 2.5% dextrose dialysis solution recall as Class II over sterility concerns

🇺🇸 FDA enforcement report · Wed 11 Nov 2026

Complaints of potential leaks from small perforations in the print area of the primary bag prompted a nationwide US recall, which remains ongoing.

The US Food and Drug Administration has listed a Class II recall of DELFLEX Peritoneal Dialysis Solution with 2.5% Dextrose, made by Fresenius Medical Care Renal Therapies Group, LLC. The recall is recorded under number D-0168-2027 in the agency's enforcement report dated 11 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA enforcement report ↗

Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.